Credit Suisse Starts Enhabit Home Health & Hospice (EHAB) at Neutral
Tweet
Share
E-mailGet Alerts EHAB Hot Sheet
Price: $13.80 --0%
Rating Summary:
1 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
1 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Credit Suisse analyst A.J. Rice initiates coverage on Enhabit Home Health & Hospice (NYSE: EHAB) with a Neutral rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Enhabit Home Health & Hospice click here. For more ratings news on Enhabit Home Health & Hospice click here.
Shares of Enhabit Home Health & Hospice closed at $15.85 yesterday.
You May Also Be Interested In
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Citi Resumes Universal Music Group NV (UMG:NA) (UMGNF) at Buy
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
